Lumasiran: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 April 2025

  • curprev 19:5919:59, 29 April 2025 Alara E. Dagsali talk contribs 14,552 bytes +14,552 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=lumsiran |aOrAn=an |drugClass=inhibits oxalate synthesis |indicationType=treatment |indication=of primary hyperoxaluria type 1 (PH1) to lower urinary and plasma oxalate levels in pediatric and adult patients |adverseReactions=*Injection site reaction *Abdominal pain* |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#..."
Retrieved from "https://www.wikidoc.org/index.php/Lumasiran"